Literature DB >> 7590108

The nocturnal polyuria syndrome (NPS).

R Asplund1.   

Abstract

1. The nocturnal polyuria syndrome (NPS) is characterized by an increased nocturnal urine output. The diurnal rhythm in the antidiuretic hormone (ADH) system is absent, and often there is no detectable ADH in the plasma at all during the night. The 24-hr urine output is normal or only moderately increased. Men without nocturnal micturition, normally have a substantial increase in their nocturnal plasma ADH, while those with a need to micturate during the night have the same ADH level at night as in the daytime. Women have lower ADH levels than men, and no nocturnal increase in ADH irrespective of nocturnal voiding. Subjects with an increased nocturnal voiding frequency due to increased nocturnal urine output have an increased thirst, most markedly at night. They often avoid drinking in the evening, but they are unable to resist the impulse to drink during the night. People with polyuria at night wake up often because of the need to void, and accordingly are often tired during the day. 2. An increased nocturnal urine output can be reduced by administration of desmopressin at night. In a short-term study of elderly sufferers from NPS, treated with 20 micrograms desmopressin as nose drops in the evening the nocturnal urine output was reduced from 65 +/- 8% of the 24-hr urine output before treatment to 50 +/- 15% during treatment. In another study elderly with NPS were treated with 40 micrograms desmopressin as an intranasal aerosol in the evening.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590108     DOI: 10.1016/0306-3623(94)00310-j

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  19 in total

Review 1.  [Aging and water metabolism in health and illness].

Authors:  M Miller
Journal:  Z Gerontol Geriatr       Date:  1999-07       Impact factor: 1.281

Review 2.  Female nocturia.

Authors:  Gitte M Hvistendahl; Jens C Djurhuus
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 3.  Management Strategies for Nocturia.

Authors:  Danielle J Gordon; Curran J Emeruwa; Jeffrey P Weiss
Journal:  Curr Urol Rep       Date:  2019-11-09       Impact factor: 3.092

4.  α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume.

Authors:  Osamu Yokoyama; Yoshitaka Aoki; Akira Tsujimura; Tetsuya Takao; Mikio Namiki; Akihiko Okuyama
Journal:  World J Urol       Date:  2010-04-13       Impact factor: 4.226

Review 5.  Nocturia × disturbed sleep: a review.

Authors:  Daniele Furtado; Helena Hachul; Monica L Andersen; Rodrigo A Castro; Manoel B Girão; Sergio Tufik
Journal:  Int Urogynecol J       Date:  2011-08-17       Impact factor: 2.894

Review 6.  Pharmacotherapy for nocturia in the elderly patient.

Authors:  Ragnar Asplund
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  Association of obstructive sleep apnea risk factors with nocturnal enuresis in postmenopausal women.

Authors:  Patrick Koo; F Dennis McCool; Lauren Hale; Katie Stone; Charles B Eaton
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

8.  Strong impact of nocturia on sleep quality in patients with lower urinary tract symptoms.

Authors:  Seung Whan Doo; Hong Jun Lee; Jin Ahn; Jae Heon Kim; Jong Hyun Yun; Won Jae Yang; Yun Seob Song
Journal:  World J Mens Health       Date:  2012-08-31       Impact factor: 5.400

Review 9.  New aspects of the classification of nocturia.

Authors:  Jeffrey P Weiss; Aaron C Weinberg; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

Review 10.  Nocturia: Current Evaluation and Treatment for Urology.

Authors:  Tony Nimeh; Pedro Alvarez; Naem Mufarreh; Lori B Lerner
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.